HA NA PRICE: Open Payments
NPI 1376127506 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$569 in 25 payments from 15 companies in 2025. Trend: 2023 $721 · 2024 $511 · 2025 $569
Food & beverage: $569
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 1 | $125 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $82 |
| Astellas Pharma US Inc | 3 | $57 |
| Hologic Sales and Service, LLC | 3 | $57 |
| ABBVIE INC. | 2 | $49 |
| Daiichi Sankyo Inc. | 2 | $31 |
| Sage Therapeutics, LLC | 2 | $30 |
| Exeltis, USA Inc. | 1 | $24 |
| Becton, Dickinson and Company | 1 | $21 |
| Teleflex LLC | 1 | $18 |
Products named: ZURZUVAE, Veozah, INJECTAFER, UBRELVY, SLYND, QULIPTA, ACESSA PROVU SYSTEM, BD Onclarity.
Industry payments across NV — which companies pay providers there.
